Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 5/2002

01-06-2002

Olive oil, seed oils and other added fats in relation to ovarian cancer (Italy)

Authors: Cristina Bosetti, Eva Negri, Silvia Franceschi, Renato Talamini, Maurizio Montella, Ettore Conti, Pagona Lagiou, Fabio Parazzini, Carlo La Vecchia

Published in: Cancer Causes & Control | Issue 5/2002

Login to get access
Metadata
Title
Olive oil, seed oils and other added fats in relation to ovarian cancer (Italy)
Authors
Cristina Bosetti
Eva Negri
Silvia Franceschi
Renato Talamini
Maurizio Montella
Ettore Conti
Pagona Lagiou
Fabio Parazzini
Carlo La Vecchia
Publication date
01-06-2002
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 5/2002
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1015760004130

Other articles of this Issue 5/2002

Cancer Causes & Control 5/2002 Go to the issue

OriginalPaper

Adenomatous polyp recurrence and physical activity in the Polyp Prevention Trial (United States)

OriginalPaper

Effects of alcohol consumption on the risk of colorectal cancer among men by anatomical subsite (Canada)

OriginalPaper

Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US

OriginalPaper

Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status?

OriginalPaper

Segregation analysis of prostate cancer in 1719 white, African-American and Asian-American families in the United States and Canada

OriginalPaper

Breast-feeding and neuroblastoma, USA and Canada
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits